Skip to main content

The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.

Publication ,  Journal Article
Grant, AO; John, JE; Nesterenko, VV; Starmer, CF; Moorman, JR
Published in: Mol Pharmacol
December 1996

Inactivation has been implicated as an important determinant of the block of Na+ channel by local anesthetic-class drugs. This proposition has been difficult to examine because agents used to modify inactivation change other channel properties and both inactivated and blocked channels do not conduct. We used site-directed mutagenesis of Phe1304 to glutamine in the linker between the third and fourth domains of the mu-1 Na+ channel to slow inactivation. Wild-type and mutant channels were expressed in frog oocytes. Macropatch and single-channel currents were recorded in cell-attached membrane patches. The F1304Q mutation increased mean open time (1.7 fold at -20 mV) and reduced the probability that the channel would fail to open. Closed times were best fit by a double-exponential function, suggesting that the inactivated state transitions were no longer absorbing. In wild-type channels, 100 microM disopyramide decreased mean open time from 1.64 +/- 0.08 to 0.34 +/- 0.04 msec. Total open time per trial was decreased 2-fold. There also was a marked increase in the fraction of null sweeps. In the inactivation-deficient mutant channel, mean and total open times were also reduced. These data indicate that even when inactivation is slowed by a localized specific mutation, open-channel block by disopyramide persists. Inactivation may not be a necessary requirement for open-channel block.

Duke Scholars

Published In

Mol Pharmacol

ISSN

0026-895X

Publication Date

December 1996

Volume

50

Issue

6

Start / End Page

1643 / 1650

Location

United States

Related Subject Headings

  • Sodium Channels
  • Sodium Channel Blockers
  • Phenylalanine
  • Pharmacology & Pharmacy
  • Mutagenesis, Site-Directed
  • Kinetics
  • Ion Channel Gating
  • Glutamine
  • Disopyramide
  • Cloning, Molecular
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grant, A. O., John, J. E., Nesterenko, V. V., Starmer, C. F., & Moorman, J. R. (1996). The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels. Mol Pharmacol, 50(6), 1643–1650.
Grant, A. O., J. E. John, V. V. Nesterenko, C. F. Starmer, and J. R. Moorman. “The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.Mol Pharmacol 50, no. 6 (December 1996): 1643–50.
Grant AO, John JE, Nesterenko VV, Starmer CF, Moorman JR. The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels. Mol Pharmacol. 1996 Dec;50(6):1643–50.
Grant, A. O., et al. “The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels.Mol Pharmacol, vol. 50, no. 6, Dec. 1996, pp. 1643–50.
Grant AO, John JE, Nesterenko VV, Starmer CF, Moorman JR. The role of inactivation in open-channel block of the sodium channel: studies with inactivation-deficient mutant channels. Mol Pharmacol. 1996 Dec;50(6):1643–1650.

Published In

Mol Pharmacol

ISSN

0026-895X

Publication Date

December 1996

Volume

50

Issue

6

Start / End Page

1643 / 1650

Location

United States

Related Subject Headings

  • Sodium Channels
  • Sodium Channel Blockers
  • Phenylalanine
  • Pharmacology & Pharmacy
  • Mutagenesis, Site-Directed
  • Kinetics
  • Ion Channel Gating
  • Glutamine
  • Disopyramide
  • Cloning, Molecular